69 related articles for article (PubMed ID: 17426072)
1. Effects of risperidone on lipid profile.
Khalili H; Dashti-Khavidaki S; Okhovatpour H; Ghaeli P
Ann Pharmacother; 2007 May; 41(5):899-900. PubMed ID: 17426072
[No Abstract] [Full Text] [Related]
2. Cross-sectional comparison of fasting lipids in normoglycemic patients with schizophrenia during chronic treatment with olanzapine, risperidone, or typical antipsychotics.
Hardy TA; Marquez E; Kryzhanovskaya L; Taylor CC; Cavazzoni P
J Clin Psychopharmacol; 2006 Aug; 26(4):405-8. PubMed ID: 16855460
[TBL] [Abstract][Full Text] [Related]
3. Olanzapine versus risperidone: weight gain and elevation of serum triglyceride levels.
Garyfallos G; Dimelis D; Kouniakis P; Sidiropoulos N; Karastergiou A; Lavrentiadis G; Giouzepas J; Fokas K
Eur Psychiatry; 2003 Oct; 18(6):320-1. PubMed ID: 14611929
[No Abstract] [Full Text] [Related]
4. Risperidone-associated increase in triglyceride levels.
Weinbrenner A; Peus V; Inta D; Englisch S; Zink M
Am J Psychiatry; 2009 Jan; 166(1):113-4. PubMed ID: 19122019
[No Abstract] [Full Text] [Related]
5. Sex difference in effects of typical and atypical antipsychotics on glucose-insulin homeostasis and lipid metabolism in first-episode schizophrenia.
Wu RR; Zhao JP; Zhai JG; Guo XF; Guo WB
J Clin Psychopharmacol; 2007 Aug; 27(4):374-9. PubMed ID: 17632222
[TBL] [Abstract][Full Text] [Related]
6. Correlations between weight changes and lipid profile changes in schizophrenic patients after antipsychotics therapy.
Huang TL; Lu CY
Chang Gung Med J; 2007; 30(1):26-32. PubMed ID: 17477026
[TBL] [Abstract][Full Text] [Related]
7. [Risperidone and edema: apropos of a case].
Masson M; Elayli R; Verdoux H
Encephale; 2000; 26(3):91-2. PubMed ID: 10951912
[No Abstract] [Full Text] [Related]
8. Changes in neuroendocrine and metabolic hormones induced by atypical antipsychotics in normal-weight patients with schizophrenia.
Popovic V; Doknic M; Maric N; Pekic S; Damjanovic A; Miljic D; Popovic S; Miljic N; Djurovic M; Jasovic-Gasic M; Dieguez C; Casanueva FF
Neuroendocrinology; 2007; 85(4):249-56. PubMed ID: 17570902
[TBL] [Abstract][Full Text] [Related]
9. Effect of risperidone on ghrelin and glucose in schizophrenia.
Cohen D
Psychiatry Clin Neurosci; 2007 Oct; 61(5):576. PubMed ID: 17875041
[No Abstract] [Full Text] [Related]
10. Effects of risperidone on glucose metabolism in Chinese patients with schizophrenia: a prospective study.
Chen Q; Cai ZJ; Mao PX; Zhai YM; Mitchell PB; Tang YL
J Psychiatr Res; 2008 Dec; 43(2):124-8. PubMed ID: 18423490
[TBL] [Abstract][Full Text] [Related]
11. [Dyslipidemia and schizophrenia].
Wetterling T; Schneider B; Weber B
Psychiatr Prax; 2007 Jul; 34(5):223-9. PubMed ID: 17160750
[TBL] [Abstract][Full Text] [Related]
12. A head-to-head comparison of sertindole and risperidone on metabolic parameters.
De Hert M; Mittoux A; He Y; Peuskens J
Schizophr Res; 2010 Nov; 123(2-3):276-7. PubMed ID: 20732794
[No Abstract] [Full Text] [Related]
13. Effects of a 10-week weight control program on obese patients with schizophrenia or schizoaffective disorder: a 12-month follow up.
Chen CK; Chen YC; Huang YS
Psychiatry Clin Neurosci; 2009 Feb; 63(1):17-22. PubMed ID: 19067997
[TBL] [Abstract][Full Text] [Related]
14. Safety profile of iloperidone: a pooled analysis of 6-week acute-phase pivotal trials.
Weiden PJ; Cutler AJ; Polymeropoulos MH; Wolfgang CD
J Clin Psychopharmacol; 2008 Apr; 28(2 Suppl 1):S12-9. PubMed ID: 18334908
[TBL] [Abstract][Full Text] [Related]
15. Increase of risperidone concentration under chlorprothixene comedication--a case report.
Bader W; Greiner C; Haen E
Pharmacopsychiatry; 2008 May; 41(3):116-7. PubMed ID: 18484554
[No Abstract] [Full Text] [Related]
16. Effects of second generation antipsychotics on leptin and ghrelin.
Esen-Danaci A; Sarandöl A; Taneli F; Yurtsever F; Ozlen N
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Aug; 32(6):1434-8. PubMed ID: 18579280
[TBL] [Abstract][Full Text] [Related]
17. [Hyperlipidemia--side-effect of the treatment with an atypical antipsychotic (zotepine)?].
Wetterling T
Psychiatr Prax; 2002 Nov; 29(8):438-40. PubMed ID: 12436365
[TBL] [Abstract][Full Text] [Related]
18. Oral versus injectable antipsychotic treatment in early psychosis: post hoc comparison of two studies.
Emsley R; Oosthuizen P; Koen L; Niehaus DJ; Medori R; Rabinowitz J
Clin Ther; 2008 Dec; 30(12):2378-86. PubMed ID: 19167596
[TBL] [Abstract][Full Text] [Related]
19. Metabolomic mapping of atypical antipsychotic effects in schizophrenia.
Kaddurah-Daouk R; McEvoy J; Baillie RA; Lee D; Yao JK; Doraiswamy PM; Krishnan KR
Mol Psychiatry; 2007 Oct; 12(10):934-45. PubMed ID: 17440431
[TBL] [Abstract][Full Text] [Related]
20. Elevated plasma γ-aminobutyrate/glutamate ratio and responses to risperidone antipsychotic treatment in schizophrenia.
Cai HL; Zhu RH; Li HD; Zhang XH; Hu L; Yang W; Ye HS
Prog Neuropsychopharmacol Biol Psychiatry; 2010 Oct; 34(7):1273-8. PubMed ID: 20637820
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
